Assistant Professor of Surgery
The University of Chicago
5841 South Maryland Avenue
MC #7118
Chicago, IL 60637
Phone: 773-834-8138
Fax: 773-834-4022
Email:
• Clinical
Interests
• Complete
Bibliography
The research focus of my laboratory group is the recognition of human adenocarcinomas by the cellular immune system and potential immune-based therapies for these tumors. Our goals are to develop treatments for advanced gastrointestinal malignancies through our scientific research and to conduct clinical trials using these agents. (read more)
McKee MD, Fichera A, Nishimura MI. T cell immunotherapy. Front Biosci 2007; 12:919-32 (PubMed)
McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 2004; 85(2):68-76 (PubMed)
Roszkowski JJ, Yu DC, Rubinstein MP, McKee MD, Cole DJ, Nishimura MI. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J Immunol 2003; 170(5):2582-9 (PubMed)
McKee MD, Posner MC. The staging of gastric cancer: nothing novel but perhaps better. Ann Surg Oncol 2003; 10(9):1005-6 (PubMed)
McKee MD, Cecco SA, Niemela JE, Cormier J, Kim CJ, Steinberg SM, Rehak NN, Elin RJ, Rosenberg SA. Effects of interleukin 2 therapy on lymphocyte magnesium levels. J Lab Clin Med 2002; 139(1):5-12 (PubMed)
McKee MD, Cropp MD, Hyland A, Watroba N, McKinley B, Edge SB. Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer 2002; 95(4):704-12 (PubMed)
McKee MD, Clay TM, Diamond RA, Rosenberg SA, Nishimura MI. Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction: dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture. J Immunother 2000; 23(4):419-29 (PubMed)
Clay TM, Custer MC, McKee MD, Parkhurst M, Robbins PF, Kerstann K, Wunderlich J, Rosenberg SA, Nishimura MI. Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue. J Immunol 1999; 162(3):1749-55 (PubMed)
McKee MD, Clay TM, Rosenberg SA, Nishimura MI. Quantitation of T-cell receptor frequencies by competitive PCR: generation and evaluation of novel TCR subfamily and clone specific competitors. J Immunother 1999; 22(2):93-102 (PubMed)
Cormier JN, Hurst R, Vasselli J, Lee D, Kim CJ, McKee M, Venzon D, White D, Marincola FM, Rosenberg SA. A prospective randomized evaluation of the prophylactic use of low-dose dopamine in cancer patients receiving interleukin-2. J Immunother 1997; 20(4):292-300 (PubMed)
